Dr. Heinz-Josef Lenz
Claim this profileUSC / Norris Comprehensive Cancer Center
Area of expertise
Colorectal Cancer
Heinz-Josef Lenz has run 19 trials for Colorectal Cancer. Some of their research focus areas include:
Colon Cancer
Heinz-Josef Lenz has run 10 trials for Colon Cancer. Some of their research focus areas include:
Affiliated Hospitals
USC / Norris Comprehensive Cancer Center
Los Angeles County-USC Medical Center
Clinical Trials Heinz-Josef Lenz is currently running
Immunotherapy
for Pancreatic Cancer
This trial tests a new treatment for pancreatic cancer using a special vaccine, a virus for delivery, and an immune-boosting drug. It aims to help the immune system better fight cancer in patients whose disease has spread, is locally advanced, or has been surgically removed. Vaccine therapy is being tested for many forms of cancer, including pancreatic cancer, with early trials showing safety and some increased survival.
Recruiting
1 award
Phase 1
Genetic Testing
for Colorectal Cancer
This study aims to better understand the cause of colorectal cancer and how to find the best treatment for Hispanic patients with colorectal cancer. The genetic information in the blood and tissues may explain why patients who have the same type of cancer and receive the same treatment do not always have the same results. By combining genetic (certain qualities or traits passed from parents to offspring) information with clinical data, such as the responses of different kinds of cancers to different treatments, this study could lead to more knowledge about why certain cancers occur and why they respond differently to treatments. Information gathered from this study may help researchers match treatments to the genetics of each patient and the genetic changes in their tumor. This approach is known as personalized medicine.
Recruiting
1 award
N/A
5 criteria
More about Heinz-Josef Lenz
Clinical Trial Related
8 years of experience running clinical trials · Led 33 trials as a Principal Investigator · 7 Active Clinical Trials
Treatments Heinz-Josef Lenz has experience with
- Ipilimumab
- Cetuximab
- Regorafenib
- Nivolumab
- Bevacizumab
- Atezolizumab
Breakdown of trials Heinz-Josef Lenz has run
Colorectal Cancer
Colon Cancer
Pancreatic Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Heinz-Josef Lenz specialize in?
Heinz-Josef Lenz focuses on Colorectal Cancer and Colon Cancer. In particular, much of their work with Colorectal Cancer has involved Stage IV patients, or patients who are Stage III.
Is Heinz-Josef Lenz currently recruiting for clinical trials?
Yes, Heinz-Josef Lenz is currently recruiting for 7 clinical trials in Los Angeles California. If you're interested in participating, you should apply.
Are there any treatments that Heinz-Josef Lenz has studied deeply?
Yes, Heinz-Josef Lenz has studied treatments such as Ipilimumab, Cetuximab, Regorafenib.
What is the best way to schedule an appointment with Heinz-Josef Lenz?
Apply for one of the trials that Heinz-Josef Lenz is conducting.
What is the office address of Heinz-Josef Lenz?
The office of Heinz-Josef Lenz is located at: USC / Norris Comprehensive Cancer Center, Los Angeles, California 90033 United States. This is the address for their practice at the USC / Norris Comprehensive Cancer Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.